Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway.
Stem Cell Res Ther
; 10(1): 213, 2019 07 19.
Article
in En
| MEDLINE
| ID: mdl-31324207
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Osteogenesis
/
Flufenamic Acid
/
Mesenchymal Stem Cells
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Stem Cell Res Ther
Year:
2019
Document type:
Article